Article ID Journal Published Year Pages File Type
8735345 Hepatobiliary & Pancreatic Diseases International 2017 9 Pages PDF
Abstract
GEM-based combination chemotherapy might improve the OS, 6-month survival, and PFS in advanced pancreatic cancer. However, combined therapy also added toxicity.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Hepatology
Preview
Gemcitabine-based combination therapy compared with gemcitabine alone for advanced pancreatic cancer: a meta-analysis of nine randomized controlled trials
Authors
, , , ,